Speaking about the importance of human challenge trials, the article coincides with the launch of Doherty Clinical Trials' facility in East Melbourne.
Doherty Clinical Trials' Chief Medical Officer, Professor James McCarthy and CEO, Dr Andrew Brockway (pictured above) were this week featured in The Age explaining the importance of human challenge trials, how they're administered and the valuable insights they can deliver to further advance medical research and help Victoria, and potentially the world, prepare for the next pandemic.
Coinciding with the launch and unveiling of the facility, currently based in East Melbourne, the article also speaks with Doherty Institute director and Doherty Clinical Trials board member, Professor Sharon Lewin, who articulated the focus of the unit - the first purpose-built human challenge facility in the Southern Hemisphere.
You can read the full article here.
Image taken from The Age article 'Virus volunteers to help Melbourne’s new human trials clinic prepare for the next pandemic', captured by Paul Jeffers.
Delving further into the Doherty Clinical Trials experience and the purposes of human challenge trials, the article is another feature highlighting the company’s launch.
Launched by Deputy Premier, The Honourable Ben Carroll MP and Professor Sharon Lewin AO, Director of the Doherty Institute in East Melbourne.
Speaking about the importance of human challenge trials, the article coincides with the launch of Doherty Clinical Trials' facility in East Melbourne.
Our Clinical Operations & Nursing Director receives prestigious Bullwinkel Scholarship award
The new home of Doherty Clinical Trials at AIID set for 2027
.jpg)
Join our database to be informed of upcoming trials and clinical studies
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}